Development of a real time PCR assay for the JAK2V617F mutation in myeloproliferative disorders

被引：0
|
作者：
Olsen, RJ
Tang, D
Bernard, DW
Farkas, DH
Chang, JCC
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Cornell Univ, Ithaca, NY USA
[3] Methodist Hosp, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1115
引用
收藏
页码：240A / 240A
页数：1
相关论文
共 50 条
  • [31] Myeloproliferative disorders "Philadelphia negative" and JAK2V617F mutation: study of 15 cases in Togo
    Padaro, Essohana
    Agbetiafa, Kossi
    Kueviakoe, Irenee Messanh Delagnon
    Layibo, Yao
    Amegbor, Koffi
    Vovor, Ahoefa
    Giraudier, Stephane
    Sanogo, Ibrahima
    Segbena, Akuete Yvon
    ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (05) : 591 - 594
  • [32] JAK2V617F mutation in leukaemic transformation of Philadelphia negative chronic myeloproliferative disorders.
    Rossi, Davide
    Deambrogi, Clara
    Capello, Daniela
    Cerri, Michaela
    Lunghi, Monia
    De Paoli, Lorenzo
    Parvis, Guido
    Saglio, Giuseppe
    Gaidano, Gianluca
    Cilloni, Daniela
    BLOOD, 2006, 108 (11) : 1030A - 1030A
  • [33] Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm
    Peyro-Saint-Paul, Helene
    Hermitte, Fabienne
    BLOOD, 2010, 116 (11) : 1994 - 1995
  • [34] Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
    Xing, Shu
    Ho, Wanting Tina
    Zhao, Wanming
    Ma, Junfeng
    Wang, Shaofeng
    Xu, Xuesong
    Li, Qingshan
    Fu, Xueqi
    Xu, Mingjiang
    Zhao, Zhizhuang Joe
    BLOOD, 2008, 111 (10) : 5109 - 5117
  • [35] Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
    Xing, Shu
    Zhao, Zhizhuang Joe
    BLOOD, 2007, 110 (11) : 745A - 745A
  • [36] The JAK2 V617F mutation in the myeloproliferative disorders
    Sale, MA
    Awan, A
    Lucas, GS
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
  • [37] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    Holmstrom, M. O.
    Hjortso, M. D.
    Ahmad, S. M.
    Met, O.
    Martinenaite, E.
    Riley, C.
    Straten, P.
    Svane, I. M.
    Hasselbalch, H. C.
    Andersen, M. H.
    LEUKEMIA, 2017, 31 (02) : 495 - 498
  • [38] The JAK2V617F mutation and thrombosis
    Austin, S. K.
    Lambert, J. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (03) : 307 - 320
  • [39] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    M O Holmström
    M D Hjortsø
    S M Ahmad
    Ö Met
    E Martinenaite
    C Riley
    P Straten
    I M Svane
    H C Hasselbalch
    M H Andersen
    Leukemia, 2017, 31 : 495 - 498
  • [40] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
12345